Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.7 |
mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |